Gapping down
In reaction to disappointing earnings/guidance: OMN -4.3% (light volume), APOL -3.3% (also discloses University of Phoenix received a subpoena on March 21, 2014), AGU -1.4%.
A few oil/gas related names showing modest weakness: E -0.8% (light volume), STO -0.7%, NBR -0.7% .
Other news: RENN -5.5% (still checking for anything specific), AGEN -4.8% (Agenus provides update on GSK MAGE-A3 Cancer Immunotherapeutic Phase 3 study in non-small cell lung cancer), INSY -4.5% (discloses departure of Chief Medical Officer Larry Dillaha), ICPT -4.2% (files for mixed securities shelf offering; announces proposed public offering of 1 mln shares of common stock: 600k sold by Intercept, 400k being sold by institutional selling stockholders), NYMT -3.8% (plans to make a public offering of 13,000,000 shares of its common stock), ARMH -2.2% (still checking), ESS -1.4% (Essex Property Trust. and BRE Properties complete $16.2 billion merger; ESS replaced CLF in the S&P 500; downgraded to Neutral from Buy at Goldman), CF -1.3% (following AGU guidance), BXMT -1.1% (commenced an underwritten public offering of 8,000,000 shares of its class A common stock).
Analyst comments: MT -2% (downgraded to Neutral from Outperform at Credit Suisse), HSTM -1.5% (downgraded to Market Perform at Northland Capital; ICD-10 delay creates near-term uncertainty), AA -1.1% (pulling back on Nomura comments -- sees significant downside risk)
A few oil/gas related names showing modest weakness: E -0.8% (light volume), STO -0.7%, NBR -0.7% .
Other news: RENN -5.5% (still checking for anything specific), AGEN -4.8% (Agenus provides update on GSK MAGE-A3 Cancer Immunotherapeutic Phase 3 study in non-small cell lung cancer), INSY -4.5% (discloses departure of Chief Medical Officer Larry Dillaha), ICPT -4.2% (files for mixed securities shelf offering; announces proposed public offering of 1 mln shares of common stock: 600k sold by Intercept, 400k being sold by institutional selling stockholders), NYMT -3.8% (plans to make a public offering of 13,000,000 shares of its common stock), ARMH -2.2% (still checking), ESS -1.4% (Essex Property Trust. and BRE Properties complete $16.2 billion merger; ESS replaced CLF in the S&P 500; downgraded to Neutral from Buy at Goldman), CF -1.3% (following AGU guidance), BXMT -1.1% (commenced an underwritten public offering of 8,000,000 shares of its class A common stock).
Analyst comments: MT -2% (downgraded to Neutral from Outperform at Credit Suisse), HSTM -1.5% (downgraded to Market Perform at Northland Capital; ICD-10 delay creates near-term uncertainty), AA -1.1% (pulling back on Nomura comments -- sees significant downside risk)